Form 4: Lilly Endowment Inc. Sells Shares of Eli Lilly & Co in Multiple Transactions

Lilly Endowment Inc. sold a total of 9,671 shares of Eli Lilly & Co. common stock in multiple transactions on June 20, 2024, at weighted average prices ranging from $902.253 to $904.245.

Summary

• Lilly Endowment Inc., a significant shareholder of Eli Lilly & Co., executed multiple sales of common stock on June 20, 2024.
• The transactions involved the disposal of 6,552 shares at a weighted average price of $902.253.
• An additional 2,919 shares were sold at a weighted average price of $903.502.
• A further 200 shares were sold at a price of $904.245.
• Following these transactions, Lilly Endowment Inc. beneficially owns 97,574,139 shares of Eli Lilly & Co. common stock.

Sentiment

Score: 5

Explanation: The document is a neutral disclosure of a stock sale, with no indication of positive or negative sentiment. It is a routine transaction.

Industry Context

This filing is a routine disclosure of stock transactions by a major shareholder, which is common in the pharmaceutical industry. Such transactions can sometimes influence market sentiment but are generally part of normal investment activity.

Comparison to Industry Standards

• Large institutional investors like Lilly Endowment Inc. frequently adjust their holdings in publicly traded companies.
• These types of transactions are common and are usually disclosed via SEC Form 4 filings.
• The sale of 9,671 shares is a relatively small transaction compared to the total holdings of 97,574,139 shares, suggesting it is not a major shift in investment strategy.
• Other large institutional investors in the pharmaceutical sector, such as Vanguard or BlackRock, also regularly report similar transactions.

Stakeholder Impact

• The sale of shares by Lilly Endowment Inc. may have a minor impact on the stock price of Eli Lilly & Co., but is unlikely to be significant given the relatively small volume of shares sold compared to the total outstanding shares.
• The transaction does not directly impact employees, customers, or suppliers.

Key Dates

Keywords

Eli Lilly & Co, Lilly Endowment Inc, stock sale, shareholder, common stock, transaction, beneficial ownership